argenx SE

argenx SE is a real momentum stock, the stock has been booming recently, and may keep doing so in the near future. argenx SE is not a good growth stock. argenx SE is not very popular among insiders. argenx SE is a mediocre stock to choose.
Log in to see more information.
argenx SE is a clinical-stage biotechnology company, which engages in the research and development o...

News

470 Shares in argenx SE (NASDAQ:ARGX) Bought by Gallacher Capital Management LLC
470 Shares in argenx SE (NASDAQ:ARGX) Bought by Gallacher Capital Management LLC

Ticker Report Gallacher Capital Management LLC acquired a new stake in argenx SE (NASDAQ:ARGX - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and...\n more…

Candriam S.C.A. Increases Stake in argenx SE (NASDAQ:ARGX)
Candriam S.C.A. Increases Stake in argenx SE (NASDAQ:ARGX)

Zolmax Candriam S.C.A. boosted its stake in argenx SE (NASDAQ:ARGX - Free Report) by 34.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The...\n more…

Hantz Financial Services Inc. Takes $209,000 Position in argenx SE (NASDAQ:ARGX)
Hantz Financial Services Inc. Takes $209,000 Position in argenx SE (NASDAQ:ARGX)

Ticker Report Hantz Financial Services Inc. purchased a new position in argenx SE (NASDAQ:ARGX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange...\n more…

Hantz Financial Services Inc. Takes Position in argenx SE (NASDAQ:ARGX)
Hantz Financial Services Inc. Takes Position in argenx SE (NASDAQ:ARGX)

Zolmax Hantz Financial Services Inc. acquired a new stake in argenx SE (NASDAQ:ARGX - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange...\n more…

iA Global Asset Management Inc. Takes Position in argenx SE (NASDAQ:ARGX)
iA Global Asset Management Inc. Takes Position in argenx SE (NASDAQ:ARGX)

Ticker Report iA Global Asset Management Inc. bought a new stake in argenx SE (NASDAQ:ARGX - Free Report) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 6,070 shares of the...\n more…

argenx to Present at Upcoming Investor Conferences
argenx to Present at Upcoming Investor Conferences

Globe Newswire August 28, 2024Amsterdam, the Netherlands argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today...\n more…